Paroxetine and neonatal withdrawal syndrome

BMJ Case Rep. 2010 Apr 29:2010:bcr12.2009.2528. doi: 10.1136/bcr.12.2009.2528.

Abstract

We report a case of neonatal withdrawal syndrome after in utero exposure to paroxetine 20 mg/day. The infant's symptoms, such as poor neonatal adaptation, respiratory distress, decerebrate posturing, irritability and tremors, commenced soon after birth and persisted for 5 days. All neonates exposed to antidepressants, particularly serotonin reuptake inhibitors (SSRIs), during the last trimester should be followed-up closely for adverse symptoms.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Depression / drug therapy*
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Neonatal Abstinence Syndrome / diagnosis*
  • Neonatal Abstinence Syndrome / etiology*
  • Paroxetine / adverse effects*
  • Pregnancy
  • Prenatal Exposure Delayed Effects

Substances

  • Antidepressive Agents, Second-Generation
  • Paroxetine